News by Subject Chemistry & Physics

In mouse models of Alzheimer's disease, the investigational drug candidates known as CMS121 and J147 improve memory and slow the degeneration of brain cells. Now, Salk researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain cells that normally occurs during aging and restoring the levels of specific molecules to those seen in younger brains.

Researchers at Worcester Polytechnic Institute (WPI) & the Central Food Technological Research Institute in India are studying the effect of probiotic yeast in preventing fungal infections.

Research led by Nicolas Bazan, MD, Ph.D., Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, has discovered unique patterns of genetic activity that may lead to the development of blinding retinal diseases.

Matthias Schott and his team are proposing a detailed research program using the LHC's ATLAS Experiment where they can undertake a targeted search for relatively heavy ALPs, which, once found, could solve the problem associated with the anomalous magnetic moment of the muon.

A previously unknown mechanism that suppresses satiety signals from the small intestine is the main finding of a new study. This may explain, first, satiety disorders in obesity and diabetes and, second, the prompt health effects of gastric bypass, a form of bariatric surgery.

Graphene, a two-dimensional structure made of carbon, is a material with excellent mechani-cal, electronic and optical properties. However, it did not seem suitable for magnetic applica-tions. Together with international partners, Empa researchers have now succeeded in synthesiz-ing a unique nanographene predicted in the 1970s, which conclusively demonstrates that car-bon in very specific forms has magnetic properties that could permit future spintronic applica-tions. The results have just been published in the renowned journal Nature Nanotechnology.